- Presentations
- 2
- Markets
- 1
Takhzyro is a brand of Lanadelumab marketed by Takeda Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lanadelumab
- Brand owner
- Takeda Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg/1 mL injection, 300 mg/2 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Takhzyro 150 mg/1 mL injectionSubcutaneous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
| Takhzyro 300 mg/2 mL injectionSubcutaneous Cold chain | Takeda Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Takhzyro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.